Although we did not find a correlation between BCL-XL and MCL-1 and patient outcome, these antiapoptotic proteins are highly expressed in the majority of SCCHN patients, suggesting their involvement in carcinogenesis. The gene discussed is MCL1; the disease is head and neck squamous cell carcinoma.